Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

NCT06326086 · clinicaltrials.gov ↗

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Advanced Lung Cancer
Sarcopenia

Interventions

DRUG: Chemotherapy drug
DRUG: Targeted Agent
DRUG: Immunotherapy

Sponsor

Prince of Songkla University